CG Oncology, Inc. revenue breakdown overview

CG Oncology, Inc. revenue for the last year amounted to 202.00 k USD, the most of which — 204.00 k USD — came from its highest performing source at the moment, Bladder-sparing Therapeutic, the year earlier bringing 191.00 k USD. The greatest contribution to the revenue figure was made by United States — last year it brought CG Oncology, Inc. 204.00 k USD, and the year before that — 191.00 k USD.